Although most non-invasive and non-muscle layer invasive urothelial carcinoma tissues showed negative or weakly positive intensity, SOX9 levels were significantly upregulated in muscle invasive urothelial carcinoma and carcinoma in situ (Figure 1). This evidence concerns the gene SOX9 and cancer.